Is Methylene Blue Safe With G6PD Deficiency? (2026)

Written by the NooBlue editorial team. We sell methylene blue, and this is one of the questions where the right answer for some readers is not to buy it. We would rather lose that sale than have you take it without knowing your G6PD status.

Read anything about methylene blue safety and G6PD deficiency comes up quickly. It is one of the few firm “do not take” rules for this compound, alongside serotonergic medicines and pregnancy. This guide explains why methylene blue is contraindicated and can be ineffective in G6PD deficiency, what the hospital research shows, how a supplement serving compares with a hospital dose, who should get tested, and which warning signs need a doctor the same day. For every exclusion in one place, see who should not take methylene blue.

What G6PD Deficiency Is

Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme found in every cell. Its main job in red blood cells is to make NADPH, which keeps the cell’s antioxidant defenses, above all glutathione, working. Red blood cells carry oxygen all day and, once mature, cannot replace damaged proteins, so they depend on this enzyme more than most cells do (Mak and Shah, StatPearls).

G6PD deficiency is the most common human enzyme defect, present in more than 400 million people worldwide. It is inherited on the X chromosome, and its global spread closely matches the regions where malaria has been common (Cappellini and Fiorelli, 2008). Most people with it feel fine day to day. The problem appears when their red blood cells meet a strong oxidative challenge: certain infections, fava beans, or certain medicines. Methylene blue is on the list of high-risk medicines.

Because the gene sits on the X chromosome, men are more often fully affected. Women can carry one affected copy and may be partly affected. More than 140 mutations have been described, and they differ in how severe the deficiency is. That is one reason a single rule, “don’t take it”, is safer than trying to guess which variant you have.

Why Methylene Blue Is Contraindicated and Can Be Ineffective in G6PD Deficiency

Methylene blue is contraindicated in G6PD deficiency for two linked reasons, and both come down to NADPH.

1. It may not work. In hospitals, methylene blue is given by injection for methemoglobinemia, a condition in which too much hemoglobin is in a form that can’t carry oxygen. To work, methylene blue has to be converted to leucomethylene blue by an enzyme that runs on NADPH. People with G6PD deficiency make too little NADPH to do that efficiently (Sikka et al., 2011). The prescribing information puts it plainly: patients with G6PD deficiency may not reduce methylene blue to its active form, so it can be ineffective in them (DailyMed).

2. It can harm red blood cells. Methylene blue that isn’t converted adds to the oxidative stress on red blood cells that already lack their main defense. The result can be hemolysis. The prescribing information states that giving methylene blue to patients with G6PD deficiency may result in severe hemolysis and severe anemia, and that the anemia can start a day or more after the dose. It lists G6PD deficiency under contraindications for that reason, as does the standard medical reference on methylene blue (Ostrovsky and Afzal, StatPearls).

A pharmacogenomics review of the methylene blue pathway maps these enzyme steps in detail (McDonagh et al., 2013). For the other side effects of methylene blue, see our methylene blue side effects guide.

Hospital Doses vs a Supplement Serving

Most of the evidence on methylene blue and G6PD deficiency comes from hospital use. The doses there are very different from a supplement, but the rule does not change.

A supplement serving is a small fraction of a hospital dose. It would be easy to conclude that the risk is therefore negligible. We don’t think that is a safe conclusion. Nobody has tested supplement doses in people with G6PD deficiency, the variants range from mild to severe, and the harm, when it happens, is serious. A smaller dose may mean a smaller oxidative challenge, but “smaller” has never been shown to mean “safe” here.

What the Research Shows

Hospital reports. A 2024 case report in the American Journal of Hematology carries its message in the title: “Beware of methylene blue in possible G6PD deficiency” (Tatarinova et al., 2024). Reviews for clinicians make the same point: known or suspected G6PD deficiency is a reason for caution before giving methylene blue, and doctors should check G6PD status where they can (Sikka et al., 2011).

The largest dataset. A pooled analysis of four randomized trials in West African children gave methylene blue as part of malaria therapy, including at 15 mg/kg per day. It included 1,005 children, 199 of them G6PD deficient. In children fully affected by the common African variant, methylene blue was linked to a significant drop in hemoglobin. Two episodes of hemolysis occurred, both in children who had received methylene blue and carried a G6PD deficiency gene. The authors judged the effect of limited clinical relevance for that variant but said it needs monitoring (Müller et al., 2013).

That study is sometimes quoted as proof that methylene blue is fine with G6PD deficiency. It isn’t. It covered one relatively mild variant, in children under medical supervision, with blood counts checked throughout. It found a real effect on hemoglobin. And G6PD variants differ widely in severity (Cappellini and Fiorelli, 2008), so a result for one variant does not carry over to the others. What the research supports is simple: risk rises with the dose and with the severity of the deficiency, and the responsible step is to know your status rather than guess.

Who Should Get Tested Before Taking Methylene Blue

Anyone who doesn’t know their G6PD status should ideally get tested before starting methylene blue. Testing matters most if:

• Your family comes from a region where malaria has been common, such as parts of Africa, the Mediterranean, the Middle East or Asia, where G6PD deficiency is more frequent.
• You are male, because the gene is on the X chromosome.
• A relative has G6PD deficiency or has been told to avoid fava beans or certain medicines.
• You had jaundice as a newborn, or you have had an episode of sudden tiredness and dark urine after an infection or a new medicine.

The test is a blood test for G6PD enzyme activity, ordered by a doctor. A normal result removes this particular concern. A low result means methylene blue is off the table, and it is worth telling every doctor and pharmacist you see, because it affects other prescriptions too.

Warning Signs of Red Blood Cell Breakdown

Hemolysis can start a day or more after a trigger. Stop taking methylene blue and see a doctor the same day if you notice:

• Unusual tiredness or weakness
• Pale skin, shortness of breath or a fast heartbeat
• Yellowing of the skin or the whites of the eyes
• Dark brown, tea-colored or cola-colored urine

Blue or green urine is different. That is the dye itself leaving your body, and it is expected with methylene blue. Dark brown urine is not. We explain other symptoms people attribute to methylene blue in methylene blue die off symptoms.

Other Medicines to Avoid With G6PD Deficiency

Methylene blue is one of several medicines linked to hemolytic crises in G6PD deficiency. A clinical reference based on the pharmacogenetics consortium’s list names these as high risk: dapsone, methylene blue, pegloticase, phenazopyridine, primaquine at standard dose, rasburicase, tafenoquine and toluidine blue. Nitrofurantoin is listed as medium risk. Infections and fava beans are common non-drug triggers (Mak and Shah, StatPearls). If you have G6PD deficiency, your doctor or pharmacist can check any new prescription against the full, regularly updated list.

For methylene blue’s other interactions, which have nothing to do with G6PD, read what not to take with methylene blue, our methylene blue interactions guide, and methylene blue and alcohol.

If Your G6PD Test Is Normal

A normal G6PD result answers this one question. It doesn’t clear you for methylene blue on its own. Check the rest of the list first.

Methylene blue is not for you if:

• You have G6PD deficiency, or you don’t know your status and belong to a higher-risk group.
• You take an SSRI, SNRI, MAOI or other serotonergic medicine. The combination can cause serotonin syndrome. See methylene blue and serotonin syndrome.
• You are pregnant or breastfeeding, or under 18.
• You have ever reacted badly to methylene blue or a related dye.

You may consider it if: your G6PD result is normal, none of the points above applies, and your doctor agrees, especially if you take any prescription medicine or have a kidney or liver condition.

If you go ahead, start with a dose you can measure. A NooBlue capsule is a fixed 5 mg of USP grade methylene blue with 10 mg of vitamin C, one a day with food. The NooBlue 1% drops give about 0.5 mg per drop if you want to start lower. A NooBlue gummy is 10 mg. Buy methylene blue made for people, not aquarium or lab grade: our guide to food grade methylene blue explains why grade labels differ. On testing, be clear about what a lab report covers. Ours, from Contract Testing Laboratories of America (CTLA), confirms the identity of the raw methylene blue ingredient and reports heavy metals. It does not certify every batch or the finished product. For daily use, read whether methylene blue is safe to take daily and how many mg of methylene blue per day.

Safety: Read Before Your First Dose

• Do not take methylene blue if you have G6PD deficiency. It can break down red blood cells.
• Do not take it if you take an SSRI, SNRI, MAOI or any other serotonergic medicine, including many antidepressants. The combination can cause serotonin syndrome.
• Not for use during pregnancy or while breastfeeding.
• Not for anyone under 18. Keep it out of reach of children.
• Talk to your doctor before use if you take any prescription medicine or have a kidney or liver condition.
• Methylene blue can turn urine blue or green. This is expected. Dark brown urine is not, and needs a doctor.
• Do not exceed the suggested serving.

The same warnings appear in the “Safety: read before use” box on every NooBlue product page.

Frequently Asked Questions

Can you take methylene blue with G6PD deficiency?

No. Methylene blue is contraindicated in G6PD deficiency because it can cause hemolytic anemia, and it can also be ineffective because the body may not convert it to its active form. No supplement dose has been shown to be safe for people with G6PD deficiency. If you don’t know your status, ask your doctor for a G6PD test before your first dose.

What condition is a contraindication to methylene blue?

The prescribing information for methylene blue injection lists two contraindications: G6PD deficiency, because of the risk of hemolytic anemia, and severe allergic reactions to methylene blue or any other thiazine dye. It also carries its strongest warning against use with serotonergic drugs such as SSRIs, SNRIs and MAOIs, and with opioids. For supplements, NooBlue adds pregnancy, breastfeeding and anyone under 18.

Why is methylene blue ineffective in G6PD deficiency?

To work, methylene blue has to be converted to leucomethylene blue by an enzyme that uses NADPH. G6PD is the key enzyme that supplies NADPH in red blood cells. With too little G6PD, too little methylene blue gets converted, so it may not work, and the unconverted methylene blue adds oxidative stress that can damage red blood cells.

Can methylene blue cause methemoglobinemia?

Yes, at high doses. A standard medical reference reports that cumulative doses of 7 mg/kg or more can cause significant toxicity, including mild methemoglobinemia. That is 490 mg for a 70 kg adult, far above a supplement serving, and one more reason never to exceed the suggested serving.

Can G6PD deficiency cause methemoglobinemia?

G6PD deficiency is best known for red blood cell breakdown under oxidative stress, not for methemoglobinemia. Methemoglobinemia usually has other causes, such as certain drugs and chemicals (the prescribing information mentions aniline and dapsone). The two can occur together, and when they do, G6PD deficiency matters because it rules out methylene blue, the usual hospital option.

How is methemoglobinemia managed in someone with G6PD deficiency?

That is a hospital decision, not a supplement question. The prescribing information tells clinicians not to use methylene blue in G6PD deficiency and to consider other options if it fails or causes hemolysis. If you have G6PD deficiency, make sure it is on your medical record so any doctor treating you knows.

How do I know if I have G6PD deficiency?

A blood test for G6PD enzyme activity, ordered by a doctor, gives a clear answer. Most people with G6PD deficiency have no symptoms between episodes, so you can’t rely on how you feel. Clues include a family history, newborn jaundice, or past episodes of dark urine and tiredness after an infection or a new medicine.

Does a small supplement dose carry the same risk as a hospital dose?

A 5 mg capsule is a small fraction of a hospital dose of 1 to 2 mg per kg. But no study has tested supplement doses in people with G6PD deficiency, and severe variants exist. The answer is still: do not take it.

Is methylene blue safe for daily use if I don’t have G6PD deficiency?

A normal G6PD result removes one risk, not all of them. You still need to rule out serotonergic medicines, pregnancy and breastfeeding, and check with your doctor if you take any prescription medicine. See is methylene blue safe to take daily and our guide for first-time users.

The Verdict

If you have G6PD deficiency, do not take methylene blue in any form, ours included. It is contraindicated because it can break down red blood cells, and it can be ineffective because your body may not activate it. If you don’t know your status, get a G6PD blood test first. If your result is normal and none of the other exclusions applies, a measured 5 mg capsule taken once a day with food is a careful way to start. You can compare all three formats on the NooBlue shop page.

Sources

1. Prescribing information for methylene blue injection (ProvayBlue), revised February 2024. DailyMed, National Library of Medicine. DailyMed
2. Ostrovsky A, Afzal M. Methylene Blue. StatPearls, updated January 2, 2026. NCBI Bookshelf NBK557593
3. Mak GK, Shah M. Glucose-6-Phosphate Dehydrogenase Deficiency. StatPearls, 2025. PubMed 29262208
4. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. The Lancet, 2008, 371(9606), 64-74. PubMed 18177777
5. Sikka P, Bindra VK, Kapoor S, et al. Blue cures blue but be cautious. Journal of Pharmacy and Bioallied Sciences, 2011, 3, 543-545. PubMed 22219589
6. McDonagh EM, Bautista JM, Youngster I, et al. PharmGKB summary: methylene blue pathway. Pharmacogenetics and Genomics, 2013, 23, 498-508. PubMed 23913015
7. Tatarinova O, Lund K, Bain BJ. Beware of methylene blue in possible G6PD deficiency. American Journal of Hematology, 2024, 99(10), 2016-2017. PubMed 38606972
8. Müller O, Mockenhaupt FP, Marks B, et al. Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs. Pharmacoepidemiology and Drug Safety, 2013, 22(4), 376-385. PubMed 23135803
9. NooBlue product pages: capsules, gummies and drops (label facts, safety box and CTLA ingredient report, read September 26, 2026).

This article is for general information and is not medical advice. If you have G6PD deficiency or any health condition, talk to a qualified healthcare professional before taking any supplement.